Skip to main content
. 2018 Apr 2;25(1):862–871. doi: 10.1080/10717544.2018.1425773

Figure 4.

Figure 4.

Time–concentration curve for CuD after oral administration of Cucurbitacin B, CuB-MMs, and CuBMMs-CPs (A) and in vivo antitumor study of normal saline, CuB, and CuB-MMs-CPs in Balb/c nude mice implanted with HepG-2 cells. Tumor volumes (B) and body weight (C) were monitored. Tumor weight was monitored at the end of the experiment (D). The result was presented as the mean ± SD (n = 6).